ILiAD Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- ILiAD Biotechnologies's estimated annual revenue is currently $1.9M per year.
- ILiAD Biotechnologies's estimated revenue per employee is $77,500
Employee Data
- ILiAD Biotechnologies has 24 Employees.
- ILiAD Biotechnologies grew their employee count by 14% last year.
ILiAD Biotechnologies's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Executive Director | Reveal Email/Phone |
4 | General Manager International Operations | Reveal Email/Phone |
5 | Controller | Reveal Email/Phone |
6 | Administrative Specialist | Reveal Email/Phone |
ILiAD Biotechnologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15.3M | 99 | 5% | N/A | N/A |
#2 | $1.1M | 7 | -30% | N/A | N/A |
#3 | $3.7M | 24 | 4% | N/A | N/A |
#4 | $4.3M | 28 | -3% | N/A | N/A |
#5 | $2.5M | 16 | N/A | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $2.5M | 16 | 7% | N/A | N/A |
#9 | $1.4M | 9 | -25% | N/A | N/A |
#10 | $0.6M | 4 | 0% | N/A | N/A |
What Is ILiAD Biotechnologies?
ILiAD Biotechnologies is utilizing its B-Tech vector platform to develop next generation vaccines to eradicate infectious diseases and improve lives. Its lead candidate, BPZE1, which has completed Phase 2 clinical trials, is the most advanced next generation vaccine for the prevention of whooping cough, a serious illness caused by Bordetella pertussis.
keywords:N/AN/A
Total Funding
24
Number of Employees
$1.9M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.7M | 25 | 0% | N/A |
#2 | $2.5M | 25 | -7% | N/A |
#3 | N/A | 26 | 8% | N/A |
#4 | $2.6M | 26 | 4% | N/A |
#5 | N/A | 27 | -4% | N/A |